Caution is recommended when using Enterprise in patients with subarachnoid hemorrhage, as these patients seem to be associated with a high rate of fatal hemorrhagic complications.
Poor Survival Among Elderly Patients With Glioblastoma May Reflect Patterns of Care

Patterns of Care in Elderly Glioblastoma Patients.
Iwamoto FM, Reiner AS, et al: Ann Neurol 2008; 64 (December): 628-634 Age, marital status, and comorbidities influence the probability of receiving radiation therapy or chemotherapy in elderly patients with glioblastoma.
Background: Glioblastoma affects all age groups, yet the peak incidence of this disease is among those aged >65 years. Clinical trials often exclude patients aged >70 years, leaving the medical community to apply outcomes data to the elderly. Objective: To assess the pattern of care in patients aged >65 years diagnosed with glioblastoma using the Surveillance, Epidemiology, and End Results (SEER) registry. Design: Retrospective cohort study based on data from 1994 to 2002 entered in the SEER registry. Methods: Patients' demographic and medical characteristics were analyzed with respect to the probability of undergoing surgery, radiation therapy, and chemotherapy within 3 months of diagnosis. Results: 5909 patients aged >65 years diagnosed with glioblastoma were identified; 4139 were analyzed. There were more men (54%) and 62% of patients were married. In total, 92% of the cohort was white. Resection, rather than biopsy, was performed in 61% of patients. The odds of undergoing surgical resection were influenced by increasing patient age (P <0.0001) and black race (P <0.008). Sixty-five percent of patients underwent radiation therapy within 3 months of diagnosis, while only 10% received chemotherapy. Among those receiving chemotherapy, 92.4% received both radiation therapy and chemotherapy, while 7.6% received chemotherapy only. Overall, 35% of the cohort received neither therapy after diagnosis. Median survival was 4 months and older age was a worse prognostic factor (P <0.0001). Unmarried patients also had a shorter survival compared to married patients (P <0.0001).
Conclusions: This population-based study allows robust data analysis of an uncommon disease. It has shown that the pattern of care of elderly patients, such as the high proportion who did not receive adjuvant therapy, may account for the overall poor survival. Reviewer's Comments: This study's strength is in the robust statistics, representing only 1.35% of all primary cancers diagnosed annually. Although there are several data points missing that would interest all neurooncologists, such as the patients' Karnofsky performance status. The analysis reveals startling findings, ie, that 35% of the cohort received neither radiation therapy nor chemotherapy. Also, that unmarried patients fare poorly compared to those with a spouse. The chemotherapy data should be regarded with some caution, given that the current "gold standard" protocol of concurrent temozolomide with radiation therapy was not published until 2005, well beyond the study period. This study does pave the way to further study and understanding of the factors that drive medical decision making among physicians and patients. (Reviewer-Kenji Muro, MD).
Increased EPC in MMD May Play Role in Increased Arteriogenesis, Angiogenesis
Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya Disease.
Rafat N, Beck GCh, et al: Stroke 2009; 40 (February): 432-438 Endothelial progenitor cells may not be entirely mediated by vascular endothelial growth factor or granulocyte-macrophage colony-stimulating factor as previously thought.
